CD68 and carcinoma: We evaluated CD68+ macrophage numbers in 10 cases of tumor-free peri-tumoral epithelia (TFE), 43 cases of low-grade dysplasia (LGD), 45 cases of high-grade dysplasia (HGD) and 110 cases of carcinoma (CA).